Internal link ProQR Therapeutics Announces Transaction Completed for Théa to Acquire Sepofarsen and Ultevursen Ophthalmic Assets December 08, 2023 at 12:30 PM UTC
Internal link ProQR Announces Third Quarter 2023 Operating and Financial Results November 07, 2023 at 12:00 PM UTC
Internal link ProQR Strengthens Leading Intellectual Property Estate for ADAR-mediated RNA Editing November 06, 2023 at 12:00 PM UTC
Internal link ProQR Announces Participation in the Chardan 7th Annual Genetic Medicines Conference September 28, 2023 at 12:00 PM UTC
Internal link ProQR Therapeutics Provides Update on Ophthalmic Assets September 27, 2023 at 11:00 AM UTC
Internal link ProQR Announces Webcast of Presentation at the Upcoming HC Wainwright 25th Annual Global Investment Conference September 07, 2023 at 12:00 PM UTC
Internal link ProQR Announces Second Quarter 2023 Operating and Financial Results August 03, 2023 at 11:00 AM UTC
Internal link ProQR Therapeutics and Laboratoires Théa Announce Agreement for Théa to Acquire ProQR’s Sepofarsen and Ultevursen Ophthalmic Assets August 01, 2023 at 11:00 AM UTC
Internal link ProQR to Present Data on its Axiomer® RNA Editing Technology at RNA Editing Summit July 06, 2023 at 11:00 AM UTC
Internal link ProQR Announces First Quarter 2023 Operating and Financial Results May 16, 2023 at 11:00 AM UTC
Internal link ProQR to Present its Axiomer® RNA Editing Technology at TIDES USA 2023 May 09, 2023 at 12:00 PM UTC
Internal link ProQR Announces Upcoming Investor Conferences in April and May April 20, 2023 at 12:00 PM UTC
Internal link ProQR Announces Annual Meeting of Shareholders to be Held May 17, 2023 April 18, 2023 at 12:00 PM UTC
Internal link ProQR Announces Initial Pipeline Targets and Highlights Axiomer® RNA Editing Platform Technology at R&D Event March 29, 2023 at 12:00 PM UTC
Internal link ProQR Announces Successful Defense of a Key Axiomer® Patent Protecting ADAR-mediated RNA Editing March 14, 2023 at 12:00 PM UTC
Internal link ProQR to Present at Upcoming Scientific and Industry Conferences March 07, 2023 at 01:00 PM UTC
Internal link ProQR Therapeutics to Host Virtual R&D Event on March 29, 2023 February 28, 2023 at 01:00 PM UTC
Internal link ProQR Announces Webcast of Presentation at Upcoming HC Wainwright BIOCONNECT Conference December 18, 2020 at 12:00 PM UTC
Internal link ProQR to Present at 3rd Annual Evercore ISI Virtual HealthCONx Conference November 18, 2020 at 12:00 PM UTC
Internal link ProQR Announces Third Quarter 2020 Operating and Financial Results November 16, 2020 at 12:00 PM UTC
Internal link ProQR Announces Virtual Presentations at American Academy of Ophthalmology (AAO) November 02, 2020 at 12:00 PM UTC
Internal link ProQR Appoints Naveed Shams, MD, PhD as Chief Scientific Officer October 05, 2020 at 11:00 AM UTC
Internal link ProQR Announces Virtual Presentations at Scientific Conferences September 24, 2020 at 08:10 PM UTC
Internal link ProQR to Participate in Upcoming Investor Conferences September 03, 2020 at 11:00 AM UTC
Internal link ProQR Announces Second Quarter 2020 Operating and Financial Results August 06, 2020 at 08:30 PM UTC